| Serial Number | 88450820 |
| Word Mark | PROTAGONIST THERAPEUTICS |
| Filing Date | Wednesday, May 29, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, September 1, 2020 |
| Registration Number | 6142951 |
| Registration Date | Tuesday, September 1, 2020 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, December 17, 2019 |
| Description of Mark | The mark consists of the word "Protagonist" in black above the word "Therapeutics" in orange to the right of the words is a DNA double helix in the colors black and orange. The entire mark is on a transparent background. |
| Certificate of Correction for Registration | In the statement, line 1, "CALIFORNIA" should be deleted, and "DELAWARE" should be inserted. |
| Indication of Colors claimed | The color(s) black and orange is/are claimed as a feature of the mark. |
| NOT AVAILABLE | "THERAPEUTICS" |
| Goods and Services | SCIENTIFIC RESEARCH, PHARMACEUTICAL RESEARCH, MEDICAL RESEARCH; TECHNICAL AND SCIENTIFIC CONSULTATION AND PRODUCT DEVELOPMENT SERVICES FOR OTHERS, IN THE FIELD OF IMMUNE MEDIATED DISEASES, INFLAMMATORY DISEASES, AND RARE DISEASES; RESEARCH AND DEVELOPMENT OF NEW PRODUCTS PERTAINING TO THE TREATMENT OF IMMUNE MEDIATED DISEASES, INFLAMMATORY DISEASES, AND RARE DISEASES, AND TO PHARMACEUTICALS; PROVIDING ON-LINE INFORMATION FOR MEDICAL RESEARCH PURPOSES, IN THE FIELDS OF IMMUNE MEDIATED DISEASES, INFLAMMATORY DISEASES, AND RARE DISEASES, TREATMENTS FOR IMMUNE MEDIATED DISEASES, INFLAMMATORY DISEASES, AND RARE DISEASES, AND PHARMACEUTICALS |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 13, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, May 10, 2016 |
| First Use In Commerce Date | Tuesday, May 10, 2016 |
| Party Name | Protagonist Therapeutics, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Newark, CA 94560 |
| Party Name | Protagonist Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Newark, CA 94560 |
| Party Name | Protagonist Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Newark, CA 94560 |
| Event Date | Event Description |
| Thursday, June 13, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, June 1, 2019 | NEW APPLICATION ENTERED |
| Friday, June 14, 2019 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, August 19, 2019 | ASSIGNED TO EXAMINER |
| Wednesday, August 21, 2019 | PRIORITY ACTION WRITTEN |
| Wednesday, August 21, 2019 | PRIORITY ACTION E-MAILED |
| Wednesday, August 21, 2019 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Tuesday, November 5, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, November 5, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, November 6, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, November 12, 2019 | ASSIGNED TO LIE |
| Wednesday, November 27, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, November 6, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, December 17, 2019 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 17, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 11, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, July 2, 2020 | TEAS STATEMENT OF USE RECEIVED |
| Thursday, July 2, 2020 | USE AMENDMENT FILED |
| Thursday, July 23, 2020 | STATEMENT OF USE PROCESSING COMPLETE |
| Friday, July 24, 2020 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Saturday, July 25, 2020 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, September 1, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, March 11, 2021 | TEAS SECTION 7 REQUEST RECEIVED |
| Thursday, March 11, 2021 | SEC 7 REQUEST FILED |
| Tuesday, July 6, 2021 | POST REGISTRATION ACTION MAILED - SEC. 7 |
| Wednesday, July 7, 2021 | POST REGISTRATION ACTION MAILED - SEC. 7 |
| Tuesday, November 28, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, November 28, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, July 23, 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, July 6, 2021 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Tuesday, July 6, 2021 | POST REGISTRATION ACTION MAILED - SEC. 7 |
| Thursday, September 16, 2021 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
| Friday, September 17, 2021 | CORRECTION UNDER SECTION 7 - PROCESSED |
| Monday, September 1, 2025 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, November 28, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, November 28, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, November 28, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |